Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 14823 | 9.89 |
09:34 ET | 2253 | 9.79 |
09:36 ET | 22337 | 9.86 |
09:38 ET | 4810 | 9.915 |
09:39 ET | 3333 | 9.8885 |
09:41 ET | 1700 | 9.86 |
09:43 ET | 5497 | 9.71 |
09:45 ET | 2424 | 9.8 |
09:48 ET | 4294 | 9.855 |
09:50 ET | 8382 | 9.87 |
09:52 ET | 3549 | 9.865 |
09:54 ET | 604 | 9.85 |
09:56 ET | 1811 | 9.86 |
09:57 ET | 2421 | 9.865 |
09:59 ET | 1733 | 9.84 |
10:01 ET | 3892 | 9.8 |
10:03 ET | 1930 | 9.845 |
10:06 ET | 1686 | 9.81 |
10:08 ET | 1460 | 9.84 |
10:10 ET | 342 | 9.86 |
10:12 ET | 211 | 9.86 |
10:14 ET | 10167 | 9.855 |
10:17 ET | 18119 | 9.96 |
10:19 ET | 19865 | 9.9999 |
10:21 ET | 3399 | 10 |
10:24 ET | 7150 | 10 |
10:26 ET | 6000 | 10 |
10:28 ET | 7175 | 10.16 |
10:30 ET | 7151 | 10.2 |
10:32 ET | 7833 | 10.19 |
10:33 ET | 13977 | 10.36 |
10:35 ET | 6488 | 10.25 |
10:37 ET | 2635 | 10.24 |
10:39 ET | 10308 | 10.225 |
10:42 ET | 4293 | 10.29 |
10:44 ET | 1406 | 10.24 |
10:46 ET | 31382 | 10.285 |
10:48 ET | 13544 | 10.399 |
10:50 ET | 1929 | 10.328 |
10:51 ET | 4825 | 10.275 |
10:53 ET | 1514 | 10.19 |
10:55 ET | 2927 | 10.31 |
10:57 ET | 7856 | 10.13 |
11:00 ET | 4342 | 10.21 |
11:02 ET | 1447 | 10.2 |
11:04 ET | 1100 | 10.15 |
11:06 ET | 915 | 10.1832 |
11:08 ET | 1549 | 10.15 |
11:09 ET | 3108 | 10.11 |
11:11 ET | 1955 | 10.14 |
11:13 ET | 828 | 10.135 |
11:15 ET | 1810 | 10.12 |
11:18 ET | 7177 | 10.22 |
11:20 ET | 15308 | 10.195 |
11:26 ET | 2923 | 10.21 |
11:27 ET | 400 | 10.195 |
11:29 ET | 900 | 10.13 |
11:31 ET | 330 | 10.1 |
11:33 ET | 1776 | 10.07 |
11:36 ET | 2992 | 10.1 |
11:38 ET | 1090 | 10.1 |
11:40 ET | 800 | 10.11 |
11:42 ET | 19000 | 9.93 |
11:44 ET | 2872 | 9.95 |
11:45 ET | 400 | 9.9203 |
11:47 ET | 300 | 9.94 |
11:49 ET | 1601 | 9.8665 |
11:54 ET | 263 | 9.9 |
11:56 ET | 100 | 9.89 |
11:58 ET | 5605 | 9.9 |
12:00 ET | 714 | 9.8825 |
12:03 ET | 352 | 9.91 |
12:05 ET | 300 | 9.92 |
12:07 ET | 300 | 9.9201 |
12:09 ET | 1950 | 9.9301 |
12:12 ET | 800 | 9.96 |
12:14 ET | 2270 | 9.96 |
12:16 ET | 2850 | 9.99 |
12:18 ET | 600 | 9.97 |
12:20 ET | 417 | 9.99 |
12:21 ET | 550 | 9.9973 |
12:23 ET | 729 | 10.02 |
12:25 ET | 880 | 10.03 |
12:27 ET | 2425 | 10.04 |
12:30 ET | 300 | 10.03 |
12:32 ET | 1900 | 10.01 |
12:34 ET | 1449 | 10.025 |
12:39 ET | 8900 | 10.02 |
12:41 ET | 1322 | 9.985 |
12:43 ET | 3379 | 10.06 |
12:45 ET | 2700 | 10.06 |
12:50 ET | 827 | 10.11 |
12:52 ET | 1417 | 10.1 |
12:54 ET | 294 | 10.11 |
12:56 ET | 2343 | 10.125 |
12:57 ET | 1700 | 10.13 |
12:59 ET | 2677 | 10.17 |
01:01 ET | 1350 | 10.145 |
01:03 ET | 400 | 10.13 |
01:06 ET | 2087 | 10.125 |
01:08 ET | 980 | 10.13 |
01:10 ET | 1502 | 10.18 |
01:12 ET | 2210 | 10.23 |
01:14 ET | 600 | 10.23 |
01:15 ET | 900 | 10.2121 |
01:17 ET | 2900 | 10.2243 |
01:19 ET | 8341 | 10.28 |
01:21 ET | 3267 | 10.3 |
01:24 ET | 1539 | 10.3 |
01:26 ET | 2700 | 10.36 |
01:28 ET | 620 | 10.35 |
01:30 ET | 1198 | 10.295 |
01:32 ET | 640 | 10.2976 |
01:33 ET | 2950 | 10.19 |
01:35 ET | 2459 | 10.16 |
01:37 ET | 3200 | 10.13 |
01:39 ET | 100 | 10.17 |
01:42 ET | 17283 | 10.255 |
01:44 ET | 300 | 10.23 |
01:46 ET | 3111 | 10.325 |
01:48 ET | 747 | 10.33 |
01:50 ET | 1650 | 10.28 |
01:51 ET | 5298 | 10.2952 |
01:53 ET | 16035 | 10.335 |
01:55 ET | 12076 | 10.315 |
01:57 ET | 300 | 10.23 |
02:00 ET | 2241 | 10.19 |
02:02 ET | 3652 | 10.21 |
02:04 ET | 2539 | 10.185 |
02:06 ET | 46424 | 10.04 |
02:08 ET | 18300 | 10.01 |
02:09 ET | 1495 | 10.09 |
02:11 ET | 350 | 10.1089 |
02:13 ET | 1750 | 10.06 |
02:15 ET | 6000 | 10.04 |
02:18 ET | 1774 | 10.05 |
02:20 ET | 624 | 10.0668 |
02:22 ET | 2554 | 10.02 |
02:24 ET | 500 | 9.99 |
02:26 ET | 400 | 10.02 |
02:27 ET | 3064 | 10 |
02:29 ET | 2807 | 9.9 |
02:31 ET | 8630 | 9.89 |
02:33 ET | 1370 | 9.9 |
02:36 ET | 2411 | 9.9 |
02:40 ET | 100 | 9.94 |
02:42 ET | 3200 | 9.98 |
02:44 ET | 100 | 9.985 |
02:45 ET | 4470 | 9.97 |
02:47 ET | 412 | 10 |
02:49 ET | 200 | 9.99 |
02:51 ET | 2220 | 9.97 |
02:54 ET | 3150 | 9.955 |
02:56 ET | 3190 | 9.935 |
02:58 ET | 783 | 9.92 |
03:00 ET | 37766 | 9.8 |
03:02 ET | 54810 | 9.794 |
03:03 ET | 5595 | 9.85 |
03:05 ET | 1309 | 9.91 |
03:07 ET | 2478 | 9.865 |
03:09 ET | 300 | 9.91 |
03:12 ET | 2020 | 9.96 |
03:14 ET | 1898 | 9.905 |
03:16 ET | 2568 | 9.94 |
03:18 ET | 3400 | 9.975 |
03:20 ET | 1104 | 10 |
03:21 ET | 6008 | 10.0099 |
03:23 ET | 2250 | 9.96 |
03:25 ET | 3379 | 10.0299 |
03:27 ET | 5445 | 10.04 |
03:30 ET | 1250 | 9.967 |
03:32 ET | 500 | 9.99 |
03:34 ET | 2889 | 9.99 |
03:38 ET | 5872 | 9.965 |
03:39 ET | 3636 | 9.97 |
03:41 ET | 1718 | 9.96 |
03:43 ET | 2522 | 9.96 |
03:45 ET | 427 | 9.99 |
03:48 ET | 2988 | 9.99 |
03:50 ET | 6822 | 10 |
03:52 ET | 19027 | 10 |
03:54 ET | 13116 | 10.0938 |
03:56 ET | 9855 | 10.07 |
03:57 ET | 7139 | 10.03 |
03:59 ET | 70096 | 10.1 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 284.2M | -2.6x | --- |
Acrivon Therapeutics Inc | 276.0M | -2.5x | --- |
enGene Holdings Inc | 295.8M | -1.4x | --- |
Rezolute Inc | 269.8M | -3.7x | --- |
Tectonic Therapeutic Inc | 265.1M | -1.6x | --- |
ESSA Pharma Inc | 303.9M | -9.7x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $365.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 36.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.45 |
EPS | $-3.90 |
Book Value | $4.72 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.